Does granulocyte-macrophage colony-stimulating factor prevent bacterial translocation in rats with surgical trauma and obstructive jaundice?

被引:0
|
作者
Demirbag, Ali E. [1 ]
Turhan, Nesrin [2 ]
Ercis, Serpil [3 ]
Hamaloglu, Erhan [4 ]
机构
[1] Turkiye Yuksek Ihtisas Postgrad Res & Training Ho, Dept Gastrointestinal Surg, Ankara, Turkey
[2] Turkiye Yuksek Ihtisas Postgrad Res & Training Ho, Dept Pathol, Ankara, Turkey
[3] Hacettepe Univ, Sch Med, Dept Microbiol & Clin Microbiol, Ankara, Turkey
[4] Hacettepe Univ, Sch Med, Dept Gen Surg, Ankara, Turkey
关键词
GM-CSF; obstructive jaundice; surgical trauma; bacterial translocation; Kupffer cell; GUT BARRIER FUNCTION; INTESTINAL PERMEABILITY; INCREASES BACTERIAL; CONTROLLED-TRIAL; FAILURE; ENDOTOXIN; BLOOD; DYSFUNCTION; ACTIVATION; MICE;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/aims: The incidence of sepsis can be decreased by preventing bacterial translocation, as the first step in enhanced host defense. The aim of this study was to prevent translocation and to increase Kupffer cell incidence by using granulocyte-macrophage colony-stimulating factor in rats with surgical trauma and obstructive jaundice. Methods: Seventy-five Sprague-Dawley rats were randomized into 8 groups. After calibration of laboratory conditions by Group 0, SHAM operations in Groups I, H, HA and common bile duct ligations in Groups III, IV, IVA and V were performed. Granulocyte-macrophage colony-stimulating factor doses were 6 mu g/kg/d in Groups II, IV; 1 mu g/kg/d in HA, IVA postoperatively; and 6 mu g/kg/d in Group V preoperatively, for 7 days. After one week, all rats were reoperated for cecal lymph node, liver and spleen biopsies for culture and histopathology. All culture specimens were identified as positive/negative/contaminated. Survivals were recorded, and after the 21(st) day surviving rats were sacrificed by decapitation. Results: There was no translocation in Group 0 in the three specimens of liver, cecal lymph node and spleen. Group V showed minimal (10%) positivity in only liver, and othergroups ranged between 20-70% in cecal lymph node, liver and spleen tissues, respectively (p<0.05). Kupffer cell incidences were higher in the granulocyte-macrophage colony-stimulating factor given groups than in controls, and lower in common bile duct ligation groups than in SHAM groups (p<0.001). Groups 0 and V showed the best (median 20 days) and Group III the worst (methan 11.7 days) survival (p<0.001). Conclusions: Not only surgical trauma but also obstructive jaundice caused high incidence of translocation, decreased number of Kupffer cells and shortened survival. Translocation ratios were decreased by granulocyte-macrophage colony-stimulating factor in the SHAM and common bile duct ligation groups. Granulocyte-macrophage colony-stimulating factor prevented the decrease in Kupffer cell incidence caused by jaundice and prolonged the survival by preventing translocation at the first step.
引用
收藏
页码:31 / 40
页数:10
相关论文
共 50 条
  • [21] Granulocyte-macrophage colony-stimulating factor as a mediator of autoimmunity in multiple sclerosis
    Kostic, Milos
    Zivkovic, Nikola
    Cvetanovic, Ana
    Stojanovic, Ivana
    JOURNAL OF NEUROIMMUNOLOGY, 2018, 323 : 1 - 9
  • [22] EFFECTS OF GRANULOCYTE COLONY-STIMULATING FACTOR AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ON RESPIRATORY BURST ACTIVITY OF NEUTROPHILS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    OHSAKA, A
    KITAGAWA, S
    YUO, A
    MOTOYOSHI, K
    FURUSAWA, S
    MIURA, Y
    TAKAKU, F
    SAITO, M
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1993, 91 (02) : 308 - 313
  • [23] CLINICAL-APPLICATIONS OF HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
    SAKAMOTO, KM
    GASSON, JC
    INTERNATIONAL JOURNAL OF CELL CLONING, 1991, 9 (06): : 531 - 541
  • [24] Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer's disease mice
    Kiyota, Tomomi
    Machhi, Jatin
    Lu, Yaman
    Dyavarshetty, Bhagyalaxmi
    Nemati, Maryam
    Yokoyama, Izumi
    Mosley, R. Lee
    Gendelman, Howard E.
    JOURNAL OF NEUROIMMUNOLOGY, 2018, 319 : 80 - 92
  • [25] Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy
    Wong, SF
    Chan, HO
    PHARMACOTHERAPY, 2005, 25 (03): : 372 - 378
  • [26] EFFECTS OF MACROPHAGE-COLONY-STIMULATING FACTOR AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ON OSTEOCLASTIC DIFFERENTIATION OF HEMATOPOIETIC PROGENITOR CELLS
    LIGGETT, W
    SHEVDE, N
    ANKLESARIA, P
    SOHONI, S
    GREENBERGER, J
    GLOWACKI, J
    STEM CELLS, 1993, 11 (05) : 398 - 411
  • [27] Granulocyte-Macrophage Colony Stimulating Factor Exerts Protective and Immunomodulatory Effects in Cortical Trauma
    Kelso, Matthew L.
    Elliott, Bret R.
    Haverland, Nicole A.
    Mosley, R. Lee
    Gendelman, Howard E.
    JOURNAL OF NEUROIMMUNOLOGY, 2015, 278 : 162 - 173
  • [28] Compartmentalization of eosinophil granulocyte-macrophage colony-stimulating factor expression in patients with asthma
    Sullivan, S
    Broide, DH
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (04) : 966 - 976
  • [29] REGULATION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND INTERLEUKIN-3 EXPRESSION
    NIMER, SD
    UCHIDA, H
    STEM CELLS, 1995, 13 (04) : 324 - 335
  • [30] POTENTIAL USES OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN CHILDREN
    FURMAN, WL
    CRIST, WM
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1991, 13 (04): : 388 - 399